Cleared Traditional

K121266 - CARDIOSCOPE

K121266 is an FDA 510(k) clearance for CARDIOSCOPE, manufactured by Pulsecor Limited. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 229-day FDA review.

K121266 · Pulsecor Limited · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2012
Decision
229d
Days
Class 2
Risk

K121266 is an FDA 510(k) clearance for the CARDIOSCOPE. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Pulsecor Limited (Crofton, US). The FDA issued a Cleared decision on December 11, 2012 after a review of 229 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Pulsecor Limited devices

FDA 510(k) Submission Details - K121266

510(k) Number K121266 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 26, 2012
Decision Date December 11, 2012
Days to Decision 229 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
104d slower than avg
Panel avg: 125d · This submission: 229d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 845
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K121266.
COMPACT DIGITAL BLOOD PRESSURE MONITOR
K122810 · Thermor , Ltd. · Feb 2013
WA SERIES: WA100
K123839 · Ningbo Diaier Electronic Co., Ltd. · Jan 2013
TRANSTEK WRIST BLOOD PRESSURE MONITOR
K123669 · Zhongshan Transtek Electronics Co., Ltd. · Dec 2012
TL-300 T-LINE NON-INVASIVE BLOOD PRESSURE MONITORING SYSTEM
K123446 · United States Gtm Medical Devices, Inc. · Dec 2012
BLIP MODEL BP-700WF
K123020 · Carematix, Inc. · Nov 2012
UFIT TEN-10
K122443 · Biosign Technologies, Inc. · Nov 2012